Molecular Markers and the Promise of Precision Medicine for Interstitial Lung Disease
Author:
Funder
National Heart Lung and Blood Institute
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine,Pulmonary and Respiratory Medicine
Reference66 articles.
1. An official American Thoracic Society/European Respiratory Society statement: update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias;Travis;Am J Respir Crit Care Med,2013
2. Multicentre evaluation of multidisciplinary team meeting agreement on diagnosis in diffuse parenchymal lung disease: a case-cohort study;Walsh;Lancet Respir Med,2016
3. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis;King;New Engl J Med,2014
4. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis;Richeldi;New Engl J Med,2014
5. A new initiative on precision medicine;Collins;New Engl J Med,2015
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Idiopathic Pulmonary Fibrosis;Pulmonomics: Omics Approaches for Understanding Pulmonary Diseases;2023
2. The role of precision medicine in interstitial lung disease;European Respiratory Journal;2022-02-03
3. Treatment of fibrotic interstitial lung disease: current approaches and future directions;The Lancet;2021-10
4. Biomarkers in Idiopathic Pulmonary Fibrosis;Idiopathic Pulmonary Fibrosis [Working Title];2021-09-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3